News & Events
Medication Errors in the Elderly Are Costing at Least $4.2 Billion Annually: Jefferson's Proof-of-Concept Study Points to a Solution
Researchers at the Jefferson School of Population Health, working with colleagues at the Parma Local Health Authority in Italy, significantly reduced the prescribing of dangerous medications for older...
Bench to Bedside: How to Fast Track Targeted Cancer Drugs with Radiation into the Clinic
Researchers from the translational research program of the National Cancer Institute and the Radiation Therapy Oncology Therapy Group have developed new guidelines to help fast track the clinical...
Researchers at Jefferson's Kimmel Cancer Center Discover New Pathways that Drive Metastatic Prostate Cancer
Elevated levels of Cyclin D1b could function as a novel biomarker of lethal metastatic disease in prostate cancer patients, according to a pre-clinical study published ahead of print on December...
Game Changing Diagnostic and Prognostic Prostate Cancer Genetic Tests Revealed by Jefferson's Kimmel Cancer Center
Researchers at the Kimmel Cancer Center at Jefferson (KCC) have developed potentially game-changing diagnostic and prognostic genetic tests shown to better predict prostate cancer survival outcomes...
Promising Drug Slows Down Advance of Parkinson's Disease and Improves Symptoms
GM1 ganglioside slowed progression of disease in patients over at least a two-year period.
Thomas Jefferson University Honoring Cancer Pioneer Axel Ullrich with Lennox K. Black International Prize
Two-day symposium Nov. 29 and 30 will focus on individualized medicine.
New Tumor Tracking Technique May Improve Outcomes for Lung Cancer Patients
Real-time approach tracks and radiates moving tumors and spares healthy tissue.
NCI Awards 'Provocative Questions' Grant to Thomas Jefferson University Researcher Scott Waldman
Scott Waldman, MD, PhD, chairman of the Department of Pharmacology and Experimental Therapeutics at Thomas Jefferson University, has been awarded one of the prestigious "Provocative...
Thomas Jefferson University Awarded NIH Grant to Study Fibrotic Skin Disease Caused by MRI Contrast Agents
Researchers at the Jefferson Institute of Molecular Medicine were awarded almost $384,000 by the National Institutes of Health to investigate the mechanisms involved in the development of a serious...
Stat5 Predicts Outcomes for Prostate Cancer Patients after Radical Prostatectomy
Growth protein could serve as a biomarker to help guide prostate cancer treatment, say Jefferson's Kimmel Cancer Center researchers.